Evidence mapPaperPMID 28114933Full record

ArticleLipids in health and disease2017

Non-high-density lipoprotein cholesterol predicts nonfatal recurrent myocardial infarction in patients with ST segment elevation myocardial infarction.

Ming Gao, Yang Zheng, Weihua Zhang, Yi Cheng, Lin Wang, Ling Qin

Open access · goldAbstract read
In one paragraph

Article in Lipids in health and disease, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
5.2field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 39 citations in OpenAlex.

  1. Article
  2. Observational
  3. Article
  4. Article
  5. Food science & nutrition · 2023
    Article
  6. Article
  7. Impact of Atherogenic Indexes in Saphenous Vein Graft Stenosis.Arquivos brasileiros de cardiologia · 2020
    Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 2 countries.

Ming GaoThe Cardiovascular Center, First Hospital of Jilin University, 71 Xinmin Street, Changchun, 130021, China.
Yang ZhengThe Cardiovascular Center, First Hospital of Jilin University, 71 Xinmin Street, Changchun, 130021, China.
Weihua ZhangThe Cardiovascular Center, First Hospital of Jilin University, 71 Xinmin Street, Changchun, 130021, China.
Yi ChengThe Cardiovascular Center, First Hospital of Jilin University, 71 Xinmin Street, Changchun, 130021, China.
Lin WangThe Cardiovascular Center, First Hospital of Jilin University, 71 Xinmin Street, Changchun, 130021, China.
Ling QinThe Cardiovascular Center, First Hospital of Jilin University, 71 Xinmin Street, Changchun, 130021, China. 1071927028@qq.com.
Jilin University · CNCenter for Translational Molecular Medicine · NL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundLipids, which are associated with atherogenesis, clotting, and the fibrinolytic pathway, may be important prognostic indicators of recurrent myocardial infarction. The aim of this study was to determine the predictive value of baseline lipid fractions for nonfatal recurrent myocardial infarction in patients with ST segment elevation myocardial infarction 2 years after primary percutaneous coronary intervention in China.

methodsCox proportional-hazards models were used to evaluate the association between potential risk factors, including lipid fractions, and the occurrence of nonfatal recurrent myocardial infarction in 2402 consecutive patients who underwent primary percutaneous coronary intervention for ST segment elevation myocardial infarction.

resultsThe cumulative incidence of recurrent myocardial infarction was 2.7% at 1 year, 3.8% at 2 years, and 5.8% at 3 years after percutaneous coronary intervention. The effects of collinearity of lipids were investigated. In concerning the principal components analysis, composing factor 1 (scoring factors were 0.689 for non-HDL, 0.702 for LDL, 0.182 for HDL) which had eigenvalues of 1.86 and explained 62% of the variability among lipid cholesterols was significantly associated with recurrent MI in the final adjusted analysis of the lipid cholesterols principal components. Non-high-density lipoprotein cholesterol was the strongest independent predictor of nonfatal recurrent myocardial infarction. The adjusted hazards ratios for nonfatal recurrent myocardial infarction were 1.26 (95% confidence interval (CI): 1.05-1.51) for non-high-density lipoprotein cholesterol, 1.17 (95% CI: 0.99-1.39) for low-density lipoprotein and 1.15 (95% CI: 0.95-1.40) for HDL. After adjusting for gender and age, the odds ratio for patients in the highest non-high-density lipoprotein cholesterol quartile was 2.10 (95% CI: 1.19-3.72).

conclusionsNon-high-density lipoprotein cholesterol value is a stronger predictor of nonfatal recurrent myocardial infarction than other lipid risk factors in patients with ST segment elevation myocardial infarction. Moreover, the occurrence of reinfarction after percutaneous coronary intervention was highest for patients in the highest non-high-density lipoprotein cholesterol quartile.

trial registrationhttp://www.chictr.org.cn/edit.aspx?pid=13583&htm=4 , registration number: ChiCTR-EPC-16008199, date of registration:2013.01.01.

Indexed as

AgedCholesterol, HDLCholesterol, LDLFemaleHumansIncidenceMaleMiddle AgedMultivariate AnalysisPrognosisProportional Hazards ModelsRecurrenceRisk FactorsST Elevation Myocardial InfarctionCholesterol, HDLCholesterol, LDLLipidPrimary percutaneous coronary interventionRecurrent myocardial infarctionSerum transaminaseST segment elevation myocardial infarction

Identifiers

PMID28114933
PMCPMC5260128
OpenAlexW2582598608

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.